Skip to content
value.today
Owlet, Inc. logo

Owlet, Inc.

OWLT
$194 Mmarket cap on Aug 1, 2026+312.8% since Jan 2024
Compare
World rank
#16,347
Revenue
$106 M
For year ending December-2025
Net income
$-40 M
-37.5% margin
SEC filing
Employees
108
As of December 31, 2025
SEC filing

Owlet, Inc. in brief

Owlet, Inc. is a listed company in the Medical Devices industry, based in Lehi, Utah, USA. Its market value was $194 M on 1 August 2026, which makes it the 16,347th largest listed company in the world and the 3,171st largest in the USA on this site. In the year to December 2025 it had sales of $106 M and a net loss of $40 M. It employs about 108 people and Kurt Workman is its chief executive. By market, the largest shares of its 2025 sales came from USA (82%) and UK (6%). Its shares trade under the symbol OWLT (NYSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Owlet, Inc.

Owlet is a leading pediatric health platform and the only company globally to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors for home use. By delivering hospital-grade technology through a consumer-friendly interface, we bridge the critical gap between clinical care and the home.

Our ecosystem—comprising clinically tested monitoring systems, an integrated video platform, and an intuitive mobile app—supports families from "night one" and throughout the most challenging parts of the parenting journey. Since 2012, more than 2.5 million parents have trusted Owlet to provide the real-time insights in support of their child's well-being and to promote restful sleep for the entire family.

From the company's annual report filed with the US SEC: read the report

Owlet, Inc. timeline

4 events, 2020–2025
  1. 2020
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 🔔
    Initial public offering as Sandbridge Acquisition Corp
    Final prospectus filed with the SEC on 16 September 2020; shares registered for exchange trading on 14 September 2020. The blank-check company later merged with the business that carries the name today.
  4. 2021
  5. ✎
    Renamed Owlet, Inc.
    Formerly Sandbridge Acquisition Corp.
  6. 2025
  7. 💰
    Record revenue of $106 million
    FY2025, the highest of the 6 years on record.

Events of Owlet, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$76 M$151 M$227 M$302 M2023202420252026

World rank over time

▲ up 1,515 places since 2022
2022-01-07: #17014#17,01420222022-12-25: #22831#22,83120222023-07-30: #26298#26,29820232024-01-05: #25143#25,14320242026-03-08: #8983#8,98320262026-08-01: #15499#15,4992026

Rank in USA: #3,530 (Jan 2022) · #4,456 (Dec 2022) · #4,867 (Jul 2023) · #4,092 (Jan 2024) · #1,704 (Mar 2026) · #3,122 (Aug 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
1.7×
Price / book
10.2×
Free cash flow yield
-5.7%
Net margin (TTM)
-8.5%
Operating margin
-7.8%
Return on equity
-50.8%
Liabilities / assets
58.6%
Net debt
$-33M
Revenue growth
+35.4%
R&D / revenue
13.3%
Revenue per employee
$979 K
Profit per employee
$-367 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2020: revenue $75M, net income $-11M$75MFY20Fiscal year ending Dec 2021: revenue $76M, net income $-72M$76MFY21Fiscal year ending Dec 2022: revenue $69M, net income $-79M$69MFY22Fiscal year ending Dec 2023: revenue $54M, net income $-33M$54MFY23Fiscal year ending Dec 2024: revenue $78M, net income $-13M$78MFY24Fiscal year ending Dec 2025: revenue $106M, net income $-40M$106MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$106M+35.4%$-8M$-40M-37.5%
Dec 2024$78M+44.5%$-20M$-13M-16.1%
Dec 2023$54M-22.0%$-29M$-33M-60.9%
Dec 2022$69M-8.8%$-85M$-79M-114.7%
Dec 2021$76M+0.6%$-56M$-72M-94.5%
Dec 2020$75M—$-7M$-11M-14.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-11M$0M$-11M$-2.27—
Dec 2024$-11M$0M$-11M$-1.57—
Dec 2023$-24M$0M$-24M$-4.53—
Dec 2022$-81M$1M$-82M$-9.98—
Dec 2021$-41M$1M$-42M$-1.13—
Dec 2020$-0M$1M$-1M$-0.48—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$114M
Net income, trailing 12 months
$-10M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $20M, net income $-9M$20MDec ’24Three months to Mar 2025: revenue $22M, net income $4M$22MMar ’25Three months to Jun 2025: revenue $26M, net income $-37M$26MJun ’25Three months to Sep 2025: revenue $32M, net income $4M$32MSep ’25Three months to Dec 2025: revenue —, net income $-9M—Dec ’25Three months to Mar 2026: revenue $22M, net income $-3M$22MMar ’26Three months to Jun 2026: revenue $34M, net income $-1M$34MJun ’26Three months to Sep 2026: revenue $30M, net income $1M$30MSep ’26

Latest quarter to Sep 2026: revenue $30M (-4.9% on a year earlier), net income $1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of Owlet, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$106 M
Operating income
$-8 M
Net income
$-40 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$86 M
Total liabilities
$50 M
Total equity
$19 M

As of December-2025

Top 68 institutional investors in Owlet, Inc.#

As of Sep 30, 2026
68 institutions held 17.3 M shares (about 59.4% of the shares outstanding) on Sep 30, 2026. The ten largest hold 49.4%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Owlet, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Eclipse Operations, LLC7,700,8350 (0.00%)26.35%$41 MNov 9, 2026
2AWM Investment Company, Inc.1,793,164+567,811 (+46.34%)6.14%$9 MNov 13, 2026
3Granahan Investment Management, LLC1,582,946-12,473 (-0.78%)5.42%$8 MNov 16, 2026
4Cannell Capital LLC1,054,481-179,572 (-14.55%)3.61%$6 MNov 16, 2026
5Vanguard Capital Management LLC716,972-84,746 (-10.57%)2.45%$4 MNov 13, 2026
6Harbor Capital Advisors, Inc.392,687+62,751 (+19.02%)1.34%$2 MOct 22, 2026
7Jacobs Levy Equity Management, Inc330,081-743 (-0.22%)1.13%$2 MNov 16, 2026
8BlackRock, Inc.327,307-2,576 (-0.78%)1.12%$2 MNov 13, 2026
9Meros Investment Management, LP302,709-24,403 (-7.46%)1.04%$2 MNov 17, 2026
10Victory Capital Management Inc239,338New0.82%$1 MNov 10, 2026
11Citadel Advisors LLC232,452-18,685 (-7.44%)0.80%$1 MNov 16, 2026
12Geode Capital Management, LLC200,852-45,069 (-18.33%)0.69%$1 MNov 6, 2026
13Man Group plc198,697+54,701 (+37.99%)0.68%$1 MNov 16, 2026
14Portolan Capital Management, LLC167,563New0.57%$1 MNov 16, 2026
15Renaissance Technologies LLC164,841-42,900 (-20.65%)0.56%$1 MNov 12, 2026
16State of Wyoming148,634New0.51%$1 MOct 28, 2026
17XTX Topco Ltd135,446-43,376 (-24.26%)0.46%$1 MNov 16, 2026
18Gsa Capital Partners LLP117,180+101,416 (+643.34%)0.40%$1 MNov 16, 2026
19Perkins Capital Management Inc116,075+9,580 (+9.00%)0.40%$1 MNov 2, 2026
20Vanguard Fiduciary Trust Co111,754-27,212 (-19.58%)0.38%$1 MNov 13, 2026
21State Street Corp111,111+5,600 (+5.31%)0.38%$1 MNov 12, 2026
22Potomac Capital Management, Inc.83,500+6,080 (+7.85%)0.29%$0 MNov 13, 2026
23Dimensional Fund Advisors LP72,700+15,366 (+26.80%)0.25%$0 MNov 4, 2026
24Marshall Wace, LLP70,326-1,422 (-1.98%)0.24%$0 MNov 13, 2026
25Colter Lewis Investment Partners LLC67,0930 (0.00%)0.23%$0 MNov 16, 2026
Show all 68: investors 26 to 68
Institutional investors 26 to 68 in Owlet, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Morgan Stanley63,855+51,412 (+413.18%)0.22%$0 MNov 13, 2026
27Goldman Sachs Group Inc57,288+30,468 (+113.60%)0.20%$0 MNov 16, 2026
28Squarepoint Ops LLC56,930-41,261 (-42.02%)0.19%$0 MNov 9, 2026
29Arax Advisory Partners52,192+23,486 (+81.82%)0.18%$0 MNov 12, 2026
30Schonfeld Strategic Advisors LLC51,739New0.18%$0 MNov 16, 2026
31Millennium Management LLC49,862-15,990 (-24.28%)0.17%$0 MNov 16, 2026
32Northern Trust Corp46,086-7,812 (-14.49%)0.16%$0 MNov 16, 2026
33UBS Group AG45,010-11,293 (-20.06%)0.15%$0 MNov 10, 2026
34Dynamic Advisor Solutions LLC44,6450 (0.00%)0.15%$0 MOct 13, 2026
35MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.43,381-5,032 (-10.39%)0.15%$0 MNov 16, 2026
36Point72 Asset Management, L.P.40,809New0.14%$0 MNov 16, 2026
37Bridgeway Capital Management, LLC36,763-3,000 (-7.54%)0.13%$0 MNov 16, 2026
38Occudo Quantitative Strategies LP33,756New0.12%$0 MNov 16, 2026
39Empowered Funds, LLC33,725New0.12%$0 MNov 13, 2026
40Algert Global LLC29,714New0.10%$0 MNov 17, 2026
41Engineers Gate Manager LP26,666New0.09%$0 MNov 16, 2026
42Ameriprise Financial Inc25,094-487,561 (-95.11%)0.09%$0 MNov 16, 2026
43Susquehanna International Group, LLP25,003New0.09%$0 MNov 16, 2026
44Mitsubishi UFJ Asset Management Co., Ltd.24,813-2,425 (-8.90%)0.08%$0 MNov 5, 2026
45Bank Of America Corp /de/19,269+1,680 (+9.55%)0.07%$0 MNov 16, 2026
46Axq Capital, LP18,296New0.06%$0 MNov 12, 2026
47HRT Financial LP16,245New0.06%$0 MNov 13, 2026
48Jump Financial, LLC15,248New0.05%$0 MNov 13, 2026
49BNP Paribas Financial Markets14,988-22,225 (-59.72%)0.05%$0 MNov 12, 2026
50Qube Research & Technologies Ltd11,390New0.04%$0 MNov 13, 2026
51Vanguard Global Advisers, LLC8,8830 (0.00%)0.03%$0 MNov 13, 2026
52Citigroup Inc3,108New0.01%$0 MNov 4, 2026
53Avion Wealth2,5000 (0.00%)0.01%$0 MNov 4, 2026
54Barclays PLC1,987+1,592 (+403.04%)0.01%$0 MNov 6, 2026
55Russell Investments Group, Ltd.1,448New0.01%$0 MNov 6, 2026
56Clearstead Advisors, LLC1,4420 (0.00%)0.00%$0 MNov 6, 2026
57Mcguire Capital Advisors Inc1,1900 (0.00%)0.00%$0 MNov 16, 2026
58Global Retirement Partners, LLC1,014+1,000 (+7142.86%)0.00%$0 MNov 10, 2026
59Wells Fargo & Company/mn6700 (0.00%)0.00%$0 MNov 16, 2026
60Royal Bank Of Canada537+512 (+2048.00%)0.00%$0 MNov 16, 2026
61Group One Trading LLC1040 (0.00%)0.00%$0 MNov 10, 2026
62Jones Financial Companies Lllp1000 (0.00%)0.00%$0 MNov 13, 2026
63Signaturefd, LLC1000 (0.00%)0.00%$0 MOct 23, 2026
64Harborfront Financial Group LLC39New0.00%$0 MNov 12, 2026
65Caitong International Asset Management Co., Ltd37+28 (+311.11%)0.00%$0 MOct 29, 2026
66Tower Research Capital LLC (TRC)36-18,562 (-99.81%)0.00%$0 MNov 16, 2026
67FMR LLC26+5 (+23.81%)0.00%$0 MNov 10, 2026
68Physician Wealth Advisors, Inc.190 (0.00%)0.00%$0 MOct 20, 2026

Mutual funds holding Owlet, Inc.#

25 funds hold shares worth $13 M (about 8.1% of the company). Since their previous reports 16 added shares and 4 sold, buying $2 M net.
Mutual funds holding Owlet, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 JNL Multi-Manager Small Cap Growth FundJackson National Asset Management, LLC591,611$3 M2.0%0.13%+32%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.520,177$3 M1.8%<0.01%no changeJun 30, 2026
🇺🇸 Embark Small Cap Equity FundHarbor Capital Advisors, Inc.326,705$2 M1.1%0.27%+41%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.242,599$1 M0.83%<0.01%−0.4%Jun 30, 2026
🇺🇸 Victory Small Cap Stock FundVictory Capital Management Inc.232,162$1 M0.79%0.12%+34%Jul 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC97,972$1 M0.34%<0.01%+4.1%May 31, 2026
🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC56,442$0 M0.19%0.27%—Jun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors55,892$0 M0.19%0.02%+42%Jun 30, 2026
🇺🇸 Global X Internet of Things ETFGlobal X Management Company LLC48,577$0 M0.17%0.11%newMay 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC39,726$0 M0.14%<0.01%no changeMay 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC36,725$0 M0.13%0.14%+158%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC33,623$0 M0.12%<0.01%+2.9%May 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP24,300$0 M0.08%<0.01%+48%Jul 31, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.18,061$0 M0.06%<0.01%newJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.10,791$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP11,221$0 M0.04%<0.01%newJul 31, 2026
🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC11,071$0 M0.04%0.02%no changeJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.7,062$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC3,769$0 M0.01%<0.01%+36%Jun 30, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP3,758$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP2,884$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP2,466$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.1,693$0 M<0.01%<0.01%−0.6%Jul 31, 2026
🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC612$0 M<0.01%<0.01%+13%Jun 30, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC96$0 M<0.01%<0.01%+10%Jul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 25 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Owlet, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$296 K
5 sales, 2 insiders
Net, 12 months
-$296 K
open market only
Insiders on file
14
since
-$433 K$0Nov 2023: bought $0 (0 trades), sold $2 K (1 trades)Nov 23Dec 2023: bought $0 (0 trades), sold $7 K (2 trades)Feb 2024: bought $0 (0 trades), sold $1 K (1 trades)Mar 2024: bought $0 (0 trades), sold $41 K (3 trades)MarMay 2024: bought $0 (0 trades), sold $13 K (2 trades)Jun 2024: bought $0 (0 trades), sold $4 K (2 trades)Oct 2024: bought $0 (0 trades), sold $689 (1 trades)OctNov 2024: bought $0 (0 trades), sold $16 K (1 trades)Dec 2024: bought $0 (0 trades), sold $4 K (1 trades)Jan 2025: bought $0 (0 trades), sold $107 K (3 trades)Jan 25Mar 2025: bought $0 (0 trades), sold $4 K (1 trades)Apr 2025: bought $0 (0 trades), sold $23 K (3 trades)May 2025: bought $0 (0 trades), sold $18 K (1 trades)MayJun 2025: bought $0 (0 trades), sold $8 K (1 trades)Jul 2025: bought $0 (0 trades), sold $17 K (2 trades)Aug 2025: bought $0 (0 trades), sold $26 K (1 trades)AugSep 2025: bought $0 (0 trades), sold $37 K (2 trades)Oct 2025: bought $0 (0 trades), sold $433 K (3 trades)Nov 2025: bought $0 (0 trades), sold $36 K (1 trades)NovJan 2026: bought $0 (0 trades), sold $33 K (2 trades)Feb 2026: bought $0 (0 trades), sold $263 K (3 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Owlet, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Kurt WorkmanPresident & CEOShares withheld for tax-20,400$4.890$100 K1.19 MForm 4
filed Zane M. BurkeDirectorGrant or award+26,785——134,787Form 4
filed Marc F. StollDirectorGrant or award+26,785——45,781Form 4
filed Laura DurrDirectorGrant or award+26,785——127,454Form 4
filed John C. KimDirectorGrant or award+26,785——278,811Form 4
filed Melissa GonzalesDirectorGrant or award+26,785——114,690Form 4
filed Kurt WorkmanPresident & CEOShares withheld for tax-21,001$5.910$124 K1.21 MForm 4
filed Kurt WorkmanPresident & CEOGrant or award+850,000——1.23 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Owlet, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
431,949
1.6% of shares · 3.95 days to cover
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-14.08 reverse split

Fails to deliver

  • : 19 shares at $4.98
  • : 12 shares at $4.88
  • : 923 shares at $5.08
  • : 856 shares at $5.79
  • : 3,573 shares at $5.81

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Owlet, Inc. scorecard#

Passes 8 of the 17 checks that could be worked out. Fiscal year 2025; market cap of Aug 1, 2026.

  • Valuationnot known
    • –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
    • –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
    • –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
  • Growth3 of 6
    • ✓Revenue grew in the newest year35.4%Revenue up 35.4% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years15.2%15.2% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median15.2%15.2% a year against Medical Devices's median of 10.8% (73 companies).
    • ✗Earnings per share grew in the newest year-2.27 vs -1.57Diluted EPS -2.27 in fiscal 2025 against -1.57 the year before (report's currency).
    • ✗Net income higher than five years earlier-$40 M-$40 M in fiscal 2025 against -$11 M in 2020.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
  • Profitability2 of 4
    • ✗Profitable in the newest year-$40 MNet income -$40 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median-7.8%-7.8% against Medical Devices's median of -8.2% (86 companies).
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-7.8%-7.8% in fiscal 2025 against -122.3% in 2022.
  • Financial health3 of 6
    • ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.85 at the end of fiscal 2025.
    • ✓Debt below equity0.1×Debt to equity 0.13 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $33 M at the end of fiscal 2025.
    • ✗Operating income covers interest five times-10.2×Operating income -10.2 times interest in fiscal 2025.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-1.26Z-score -1.26 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year65.2%Diluted shares up 65.2% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Owlet, Inc.'s statements, beside the median of Medical Devices.

Owlet, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-7.8%-8.2%
Net margin-37.5%-10.4%
Revenue growth, 3 years a year15.2%10.8%
Revenue growth35.4%10.4%
Debt to equity0.13×0.64×
Free cash flow margin-10.5%-1.9%

4of 9on the Piotroski tests of financial strength

  • Net loss of $40 million, the 6th loss-making year in a row.
  • Free cash flow was negative: -$11 million.
  • The share count rose 65.2% in the year.
  • Operating income covers the interest bill only -10.2 times.

Owlet, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Owlet, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue1067854697675
Cost of revenue523931464140
Gross profit543923233536
Research and development149.810282110
Selling and marketing181614383719
General and administrative293427423213
Operating expenses6260511089143
Operating income−8.3−20−29−85−56−7.0
Interest expense and finance costs0.81.63.21.11.81.4
Net interest income—−1.3————
Other non-operating income (expense)−317.7−4.35.3−16−3.5
Income before tax−40−12−33−79−72−11
Income tax0.00.10.00.00.00.0r
Net income attributable to shareholders−40−13−33−79−72−11
Earnings per share, basic-2.31-1.57-4.53-9.98r-1.13-0.48
Earnings per share, diluted-2.27-1.57-4.53-9.98r-1.13-0.48
Shares, weighted average (basic)18118.38.0r6322
Shares, weighted average (diluted)18118.38.0r6322
Balance sheet
Cash and cash equivalents3520r17119517r
Receivables2312r14161011
Inventory15116.519187.9
Other current assets2.72.82.95.6120.1
Current assets8246r405113638r
Property, plant and equipment0.30.10.41.11.91.7
Right-of-use (leased) assets0.10.10.92.30—
Other intangible assets1.41.02.22.31.70.6
Total assets8649r445814040r
Accounts payable121114302816
Debt due within a year117.415r108.52.0
Current liabilities4437r45676947r
Long-term debt2.54.3008.010
Lease liabilities (non-current)0.00.10.01.20—
Total liabilities5067r74698561r
Retained earnings−307r−268r−256−223−143−72r
Shareholders' equity19−30r−38r−1155−68r
Total liabilities and equity8649r445814040r
Shares outstanding27168.88.2r11322
Cash-flow statement
Depreciation and amortization0.50.50.81.41.10.9
Share-based compensation9.38.69.9134.31.1
Cash from operating activities−11−11−24−81−41−0.1
Capital expenditure−0.3−0.0−0.0−0.6−1.0−1.0
Intangible assets bought−0.1−0.1−0.0−0.9−1.1−0.1
Cash from investing activities−0.9−0.8−0.1−1.6−2.0−1.1
Debt issued——0.505.03.0
Debt repaid−0.5−5.0−3.5−6.0−1.00
Shares issued3211r0———
Cash from financing activities321629−0.91216.5
Change in cash204.15.3−84785.3
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Owlet, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Countries and regions

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where Owlet, Inc. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Owlet, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office$87 M82%
🇬🇧 UK$6 M5.6%

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Owlet, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$4.2 M
Kurt Workman
Other top executives, average
$2.4 M
the CEO earned 1.8× this
$100 invested is now
$207
Owlet, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Kurt Workman$4.2 M$7.7 M$2.4 M$207
2024Kurt Workman$987 K$920 K$1.1 M$57
2023Kurt Workman$269 K−$88 K$687 K$67

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Owlet, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 7 · Material agreement 6 · New debt 2 · Unregistered share sale 3 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 10

Owlet, Inc.: events reported to the SEC
FiledWhat happenedFiling
Directors and officersShareholder vote8-K
Results announced8-K
Material agreementNew debt8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officersBylaws or fiscal year changedShareholder vote8-K
Directors and officers8-K
Material agreementUnregistered share sale8-K/A
Material agreementUnregistered share sale8-K
Directors and officersResults announced8-K
Material agreement8-K
Results announced8-K
Results announced8-K
Results announced8-K
Bylaws or fiscal year changed8-K
Material agreement8-K
Material agreementNew debtUnregistered share sale8-K
Directors and officersShareholder vote8-K
Results announced8-K
Directors and officers8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Aug 14, 2026

Layoffs at Owlet, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
74
2022–2022
Latest
74 people
2022-07-21
Owlet, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2022······74·····74
Owlet, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
74 peopleRestructuring planSEC 8-K“As part of the restructuring program implementation, the Company commenced a workforce reduction of approximately 74 employees that is expected to be substantially completed in the…”Filing

Source: State WARN notices and SEC 8-K item 2.05

How Owlet, Inc. compares in Medical Devices

  • Market cap$194 M · higher than 41% of 142
  • Revenue$106 M · higher than 43% of 155
  • Net margin-8.4% · higher than 48% of 144
  • Revenue growth35.4% · higher than 87% of 104
  • Price / sales1.7× · lower than 69% of 96
  • Price / book10.2× · lower than 14% of 99
  • FCF yield-5.7% · higher than 39% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Owlet, Inc.🇺🇸$194 M—-8.4%+35.4%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Aug 1, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Owlet, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Owlet, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Owlet, Inc.? Suggest a correction